Organisational initiatives to improve care in the prevention and management of cardiometabolic conditions: A scoping review

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Nutrition Metabolism and Cardiovascular Diseases Pub Date : 2024-09-10 DOI:10.1016/j.numecd.2024.09.004

Hellena Hailu Habte-Asres , Chuyou Hou , Angus Forbes , David C. Wheeler

{"title":"Organisational initiatives to improve care in the prevention and management of cardiometabolic conditions: A scoping review","authors":"Hellena Hailu Habte-Asres , Chuyou Hou , Angus Forbes , David C. Wheeler","doi":"10.1016/j.numecd.2024.09.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>Cardiometabolic conditions such as cardiovascular disease, type 2 diabetes, and chronic kidney disease contribute to multimorbidity, posing a global health challenge. However, existing healthcare frameworks often struggle to adequately address the intricate needs of individuals living with these conditions. The review aims to map existing research on cardiometabolic care initiatives for the primary and secondary prevention of metabolic conditions.</div></div><div><h3>Data synthesis</h3><div>A scoping review was conducted following the methodology of the Joanna-Briggs-Institute. We searched Medline, Embase, and CINAHL. The review primarily sought studies comparing the effectiveness of cardiometabolic services/clinics in primary or secondary prevention of cardiometabolic conditions with standard care. The data from these studies were charted and summarised in tabular form, with a narrative synthesis.</div><div>The search identified 97 records across three databases, and 18 documents met inclusion criteria. Two studies addressed cardiometabolic care in primary prevention, while twelve focused on secondary prevention. Positive outcomes were observed in primary prevention, including reductions in waist circumference, body mass index, blood pressure, and cholesterol levels. For secondary prevention, the studies demonstrated positive metabolic outcomes, such as reductions in HbA1c, weight, blood pressure, and cholesterol levels. Additionally, data from the available studies reported improved adherence to diabetes care processes and the implementation of guideline-directed therapies.</div></div><div><h3>Conclusion</h3><div>This scoping review highlights the potential benefits of services such as cardiometabolic clinics for primary and secondary prevention in metabolic conditions. Future studies should use standardised outcome measures and include details on the structure, staffing and treatment intensity of clinics to aid their wider implementation.</div></div>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nutrition Metabolism and Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0939475324003533","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Aim

Cardiometabolic conditions such as cardiovascular disease, type 2 diabetes, and chronic kidney disease contribute to multimorbidity, posing a global health challenge. However, existing healthcare frameworks often struggle to adequately address the intricate needs of individuals living with these conditions. The review aims to map existing research on cardiometabolic care initiatives for the primary and secondary prevention of metabolic conditions.

Data synthesis

A scoping review was conducted following the methodology of the Joanna-Briggs-Institute. We searched Medline, Embase, and CINAHL. The review primarily sought studies comparing the effectiveness of cardiometabolic services/clinics in primary or secondary prevention of cardiometabolic conditions with standard care. The data from these studies were charted and summarised in tabular form, with a narrative synthesis.

The search identified 97 records across three databases, and 18 documents met inclusion criteria. Two studies addressed cardiometabolic care in primary prevention, while twelve focused on secondary prevention. Positive outcomes were observed in primary prevention, including reductions in waist circumference, body mass index, blood pressure, and cholesterol levels. For secondary prevention, the studies demonstrated positive metabolic outcomes, such as reductions in HbA1c, weight, blood pressure, and cholesterol levels. Additionally, data from the available studies reported improved adherence to diabetes care processes and the implementation of guideline-directed therapies.

Conclusion

This scoping review highlights the potential benefits of services such as cardiometabolic clinics for primary and secondary prevention in metabolic conditions. Future studies should use standardised outcome measures and include details on the structure, staffing and treatment intensity of clinics to aid their wider implementation.

查看原文本刊更多论文

改善心脏代谢疾病预防和管理护理的组织举措：范围综述。

目的：心血管疾病、2 型糖尿病和慢性肾病等心脏代谢疾病导致多病并发，对全球健康构成挑战。然而，现有的医疗保健框架往往难以充分满足这些疾病患者的复杂需求。本综述旨在梳理有关心脏代谢护理措施的现有研究，以便对代谢疾病进行一级和二级预防：我们按照乔安娜-布里格斯研究所（Joanna-Briggs-Institute）的方法进行了范围界定综述。我们检索了 Medline、Embase 和 CINAHL。该综述主要寻求将心脏代谢服务/诊所在心脏代谢疾病一级或二级预防中的有效性与标准护理进行比较的研究。这些研究的数据以图表形式进行了记录和总结，并进行了叙述性综合。搜索结果在三个数据库中发现了 97 条记录，其中 18 篇文献符合纳入标准。其中两项研究涉及一级预防中的心脏代谢护理，十二项研究侧重于二级预防。在一级预防中观察到了积极的结果，包括腰围、体重指数、血压和胆固醇水平的降低。在二级预防方面，研究显示了积极的代谢结果，如 HbA1c、体重、血压和胆固醇水平的降低。此外，现有研究数据还显示，糖尿病护理流程的依从性和指南指导疗法的实施情况均有所改善：本范围综述强调了心脏代谢门诊等服务对代谢疾病一级和二级预防的潜在益处。未来的研究应使用标准化的结果测量方法，并详细介绍诊所的结构、人员配备和治疗强度，以帮助其更广泛地实施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nutrition Metabolism and Cardiovascular Diseases 医学-内分泌学与代谢

CiteScore

6.80

自引率

2.60%

发文量

332

审稿时长

57 days

期刊介绍： Nutrition, Metabolism & Cardiovascular Diseases is a forum designed to focus on the powerful interplay between nutritional and metabolic alterations, and cardiovascular disorders. It aims to be a highly qualified tool to help refine strategies against the nutrition-related epidemics of metabolic and cardiovascular diseases. By presenting original clinical and experimental findings, it introduces readers and authors into a rapidly developing area of clinical and preventive medicine, including also vascular biology. Of particular concern are the origins, the mechanisms and the means to prevent and control diabetes, atherosclerosis, hypertension, and other nutrition-related diseases.